Back to Search
Start Over
Supplementary Table 1 from Combined MEK and BCL-2/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient–Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Table 1 shows the p53 mutation in the PDX models
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....69f3db0b7a29c1e25126035ed9cad659
- Full Text :
- https://doi.org/10.1158/1535-7163.22505619